ezetimibe has been researched along with Arterial Diseases, Carotid in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Daum, A; Gallego-Colon, E; Yosefy, C | 1 |
| Amarenco, P; Bruckert, E; Charles, H; Gabriel Steg, P; Giroud, M; Hobeanu, C; Labreuche, J; Lavallée, PC; Meseguer, E; Touboul, PJ; Vicaut, É | 1 |
| De Simone, B; Di Taranto, MD; Fortunato, G; Gentile, M; Giacobbe, C; Iannuzzi, A; Iannuzzo, G; Jossa, F; Marotta, G; Rubba, P; Sodano, M | 1 |
| Ai, XB; Li, L; Wang, F; Wang, J; Yi, XL; Zou, YW | 1 |
| Mikhailidis, DP; Paraskevas, KI | 1 |
| Du, S; Han, YG; Li, L; Luo, P; Wang, GG; Wang, LX; Wu, SL; Zhu, HH | 1 |
| D'Agata, BM; Scardi, S; Umari, P | 1 |
| Spence, JD | 1 |
| Fleg, JL; Galloway, JM; Henderson, JA; Howard, BV; Howard, WJ; Mete, M; Ratner, RE; Roman, MJ; Silverman, A; Stylianou, M; Umans, JG; Weir, MR; Wilson, C | 1 |
| Stein, EA | 2 |
| Parhofer, K | 1 |
| Lester, SJ; Mookadam, F; Moustafa, SE; Warsame, T | 1 |
| Bogiatzi, C; Spence, JD | 1 |
| Stanek, EJ; Taylor, AJ; Villines, TC | 1 |
| Al-Abri, A; Al-Dhuhli, H; Al-Hashmi, K; Al-Hinai, AT; Al-Rasadi, K; Al-Sabti, H; Al-Waili, K; Al-Yaarubi, S; Al-Zakwani, I; Banerjee, Y | 1 |
2 review(s) available for ezetimibe and Arterial Diseases, Carotid
| Article | Year |
|---|---|
Statins and PCSK9 inhibitors: A new lipid-lowering therapy.
Topics: Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Carotid Artery Diseases; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Guidelines as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; PCSK9 Inhibitors; Receptors, LDL; Risk Factors; Serine Proteinase Inhibitors; Treatment Outcome | 2020 |
Subclinical atherosclerosis: evolving role of carotid intima-media thickness.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Azetidines; Carotid Arteries; Carotid Artery Diseases; Disease Progression; Ezetimibe; Humans; Prognosis; Risk Factors; Tunica Intima; Tunica Media | 2010 |
5 trial(s) available for ezetimibe and Arterial Diseases, Carotid
| Article | Year |
|---|---|
Carotid Atherosclerosis Evolution When Targeting a Low-Density Lipoprotein Cholesterol Concentration <70 mg/dL After an Ischemic Stroke of Atherosclerotic Origin.
Topics: Aged; Aged, 80 and over; Carotid Artery Diseases; Cholesterol, LDL; Ezetimibe; Female; Follow-Up Studies; Humans; Ischemic Stroke; Male; Middle Aged; Ultrasonography | 2020 |
Efficacy of ezetimibe combined with atorvastatin in the treatment of carotid artery plaque in patients with type 2 diabetes mellitus complicated with coronary heart disease.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Carotid Artery Diseases; Carotid Intima-Media Thickness; China; Coronary Artery Disease; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Ezetimibe; Female; Glycated Hemoglobin; Humans; Lipids; Male; Middle Aged; Plaque, Atherosclerotic | 2017 |
Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.
Topics: Anticholesteremic Agents; Azetidines; Biomarkers; Carotid Artery Diseases; Carotid Artery, Common; Cholesterol, LDL; Diabetes Complications; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linear Models; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Tunica Intima; Tunica Media | 2008 |
Ezetimibe and regression of carotid atherosclerosis: importance of measuring plaque burden.
Topics: Aged; Anticholesteremic Agents; Azetidines; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cholesterol, LDL; Ezetimibe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Triglycerides | 2012 |
Paradoxical progression of atherosclerosis related to low-density lipoprotein reduction and exposure to ezetimibe.
Topics: Aged; Anticholesteremic Agents; Atherosclerosis; Azetidines; Carotid Artery Diseases; Carotid Artery, Common; Carotid Intima-Media Thickness; Cholesterol, LDL; Coronary Artery Disease; Coronary Disease; Disease Progression; Ezetimibe; Female; Humans; Male; Risk Factors | 2012 |
10 other study(ies) available for ezetimibe and Arterial Diseases, Carotid
| Article | Year |
|---|---|
Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
Topics: Age of Onset; Anticholesteremic Agents; Apolipoprotein B-100; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cholesterol, LDL; DNA Mutational Analysis; Ezetimibe; Genetic Association Studies; Genetic Predisposition to Disease; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Italy; Mutation; Mutation Rate; Phenotype; Plaque, Atherosclerotic; Prevalence; Proprotein Convertase 9; Receptors, LDL; Retrospective Studies; Risk Factors; Treatment Outcome | 2017 |
More on carotid atherosclerosis and ezetimibe.
Topics: Atorvastatin; Carotid Artery Diseases; Carotid Stenosis; Coronary Disease; Diabetes Mellitus, Type 2; Ezetimibe; Humans | 2017 |
Effects of atorvastatin in combination with ezetimibe on carotid atherosclerosis in elderly patients with hypercholesterolemia.
Topics: Aged; Atorvastatin; Azetidines; C-Reactive Protein; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cholesterol, LDL; Drug Combinations; Ezetimibe; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Pyrroles | 2014 |
[Lower is better: ENHANCE affair].
Topics: Anticholesteremic Agents; Azetidines; Carotid Artery Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Ezetimibe; Humans; Publication Bias; Simvastatin; Ultrasonography | 2008 |
Is carotid intima-media thickness a reliable clinical predictor?
Topics: Anticholesteremic Agents; Atherosclerosis; Azetidines; Carotid Arteries; Carotid Artery Diseases; Coronary Disease; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Simvastatin; Tunica Intima; Tunica Media | 2008 |
Additional lipid lowering trials using surrogate measurements of atherosclerosis by carotid intima-media thickness: more clarity or confusion?
Topics: Anticholesteremic Agents; Azetidines; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Cholesterol, LDL; Diabetes Complications; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Tunica Intima; Tunica Media | 2008 |
[Statin plus niacin or ezetimibe? What combination for which patients?].
Topics: Anticholesteremic Agents; Atherosclerosis; Azetidines; Carotid Artery Diseases; Coronary Disease; Drug Therapy, Combination; Ezetimibe; Humans; Hypolipidemic Agents; Niacin; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Time Factors | 2009 |
First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene.
Topics: Achilles Tendon; Anticholesteremic Agents; Apolipoproteins B; Azetidines; Biomarkers; Blood Component Removal; Carotid Artery Diseases; Carotid Intima-Media Thickness; Child; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; DNA Mutational Analysis; Drug Combinations; Exons; Eye Diseases; Ezetimibe; Female; Fluorobenzenes; Frameshift Mutation; Genetic Predisposition to Disease; Homozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Oman; Pedigree; Phenotype; Pyrimidines; Receptors, LDL; Rosuvastatin Calcium; Sequence Deletion; Sulfonamides; Treatment Outcome; Triglycerides; Xanthomatosis | 2013 |
In brief: Zetia and Vytorin: the ENHANCE study.
Topics: Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Carotid Artery Diseases; Cholesterol, LDL; Drug Combinations; Ezetimibe; Ezetimibe, Simvastatin Drug Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Randomized Controlled Trials as Topic; Simvastatin; Treatment Outcome | 2008 |
After ENHANCE: is more LDL cholesterol lowering even better?
Topics: Anticholesteremic Agents; Atherosclerosis; Azetidines; Biomarkers; Carotid Artery Diseases; Cholesterol, LDL; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Inflammation; Lipid Metabolism; Simvastatin | 2008 |